NCT00499317 Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
| NCT ID | NCT00499317 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston Children's Hospital |
| Condition | Chronic Prostatitis (CP) |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2007-01-15 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2007-01-15 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is a condition with several causes of which some remain unknown. It is believed that some types of CP may be genetic or passed down (inherited) from one generation to the next. In this study, we are collecting genetic material and medical information to try to determine if genetic factors play a role in CP/CPPS. We will be collecting DNA (from Blood/Saliva sample) and urine from each participant. Bladder tissue from affected individuals will also be collected. Individuals and families with CP/CPPS will be enrolled. Family members of an individual with CP/CPPS are eligible whether or not they also experience CP/CPPS symptoms.
Eligibility Criteria
Inclusion Criteria: * Have symptoms for at least 3 months within the preceding 6 months: * Pain in the pelvic area * Urinary frequency and/or * Urinary urgency and/or * Sexual dysfunction (erectile dysfunction) * Have CP/CPPS, Interstitial Cystitis (IC), Bladder Pain Syndrome BPS, or Bladder Fasciculation Syndrome (BFS) * Be willing to provide a blood/saliva, bladder tissue (from previous biopsy) and urine sample * Agree to complete several brief questionnaires * Family member of someone with CP/CPPS, BPS, IC or BFS * Live in the USA or Canada Exclusion Criteria: * Major structural/anatomical urinary tract abnormalities * Underlying inborn or congenital conditions which affect the urinary tract * Surgery/chemotherapy in the pelvic area * Bacterial cause to CP/CPPS or recurrent Urinary tract infections (UTI) * Traumatic cause to CP/CPPS
Contact & Investigator
Catherine Brownstein, PhD
PRINCIPAL INVESTIGATOR
Boston Children's Hospital
Frequently Asked Questions
Who can join the NCT00499317 clinical trial?
This trial is open to participants of all sexes, studying Chronic Prostatitis (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00499317 currently recruiting?
Yes, NCT00499317 is actively recruiting participants. Contact the research team at elicia.estrella@childrens.harvard.edu for enrollment information.
Where is the NCT00499317 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT00499317 clinical trial?
NCT00499317 is sponsored by Boston Children's Hospital. The principal investigator is Catherine Brownstein, PhD at Boston Children's Hospital. The trial plans to enroll 500 participants.